CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,563
- in 6 filings
Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | Boniface John J. Chief Scientific Officer | Option exercise 10b5-1 | +24,474 | $0.91 | $22K | 164,245 |
| 2024-03-28 | Boniface John J. Chief Scientific Officer | Sale 10b5-1 | −24,474 | $9.04 | $221K | 139,771 |
| 2024-03-28 | Boniface John J. Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −24,474 | 0 | ||
| 2024-03-27 | Boniface John J. Chief Scientific Officer | Sale 10b5-1 | −3,753 | $9.62 | $36K | 139,771 |
| 2024-03-27 | Boniface John J. Chief Scientific Officer | Option exercise 10b5-1 | +48,909 | $0.91 | $45K | 188,680 |
| 2024-03-27 | Boniface John J. Chief Scientific Officer | Sale 10b5-1 | −48,909 | $9.62 | $471K | 139,771 |
| 2024-03-27 | Boniface John J. Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −48,909 | 24,474 | ||
| 2024-03-26 | Lindgardt Zhenya Chief Executive Officer | Sale | −38,899 | $9.37 | $364K | 908,104 |
| 2024-03-26 | Aerts Austin Chief Financial Officer | Sale | −8,092 | $9.37 | $76K | 322,488 |
| 2024-03-26 | Boniface John J. Chief Scientific Officer | Sale | −21,438 | $9.55 | $205K | 143,524 |
| 2024-03-25 | Boniface John J. Chief Scientific Officer | Sale | −22,163 | $9.10 | $202K | 164,962 |
| 2024-03-06 | Boniface John J. Chief Scientific Officer | Sale | −1,664 | $9.02 | $15K | 187,125 |
| 2024-03-06 | Aerts Austin Chief Financial Officer | Sale | −444 | $9.02 | $4K | 330,580 |
| 2024-03-06 | Kearney Paul Chief Data Officer | Sale | −1,028 | $9.02 | $9K | 159,038 |
| 2024-03-06 | Harrison Robert Gardner Chief Information Officer | Sale | −2,138 | $9.02 | $19K | 145,697 |
| 2024-03-06 | Jackson Benjamin General Counsel | Sale | −1,856 | $9.02 | $17K | 150,179 |
Page 15 of 15 · 296 trades